Highly significant heterogeneity was observed in both the χ 2 and I 2 tests, hence the implication that all studies evaluate the same effect was decisively rejected.
← all excerpts
Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis.
2
—
—
The sentences
HR = 0.8077 (95% CI 0.5704; 1.1438) and this suggests a 19.23% risk reduction in patients receiving surgery compared to no treatment that did not reach statistical significance.